Pemoline


w95



General information:


Withdrawn ID: w95
Canonical SMILES:
Standard InChI:
Standard InChIKey:
ATC class(es): N06BA05
Molecular Formula: C9H8N2O2
Molweight: 176.172



Withdrawal information:


Withdrawn due to drug safety reasons:Yes
First approved: 1975
First death: 1989
First withdrawn: 1997
Last withdrawn: 1997
Reference: https://www.ncbi.nlm.nih.gov/pubmed/21574210



Side-effects:

Total reported cases (submitted by medical professionals) with Pemoline as primary suspect: 13


Reported final outcomes:
Hospitalization (initial or prolonged): 3
Intervention required to prevent permanent impairment/damage: 2
Death: 2
Disability: 1
Life-Threatening condition: 1


Reported side-effects:

Side-effect Case number
AGITATION2
ASCITES2
PHARMACEUTICAL PRODUCT COMPLAINT2
FEELING JITTERY2
DRUG INEFFECTIVE2
CEREBROVASCULAR ACCIDENT1
HEPATITIS TOXIC1
HEPATIC NECROSIS1
HEPATIC FIBROSIS1
HEPATIC FAILURE1
HEPATIC ENCEPHALOPATHY1
GRANDIOSITY1
FEELING OF DESPAIR1
FEELING ABNORMAL1
FATIGUE1
DISTURBANCE IN SOCIAL BEHAVIOUR1
DISTURBANCE IN ATTENTION1
INFLAMMATION1
CARBON MONOXIDE POISONING1
BEREAVEMENT REACTION1
APHAGIA1
APATHY1
ANXIETY1
ALCOHOL USE1
AGGRESSION1
ABNORMAL BEHAVIOUR1
ABDOMINAL DISTENSION1
MYOCARDIAL INFARCTION1
THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION1
SUICIDAL IDEATION1
SUDDEN CARDIAC DEATH1
STRESS SYMPTOMS1
SPLENOMEGALY1
RELATIONSHIP BREAKDOWN1
REBOUND EFFECT1
PSYCHOMOTOR HYPERACTIVITY1
PORTAL HYPERTENSION1
PAIN1
OVERDOSE1
OEDEMA PERIPHERAL1
HEPATOMEGALY1
MOOD ALTERED1
MENTAL DISORDER1
MANIA1
LOSS OF EMPLOYMENT1
LIVER TRANSPLANT1
LIVER INJURY1
LIVER FUNCTION TEST ABNORMAL1
LISTLESS1
JAUNDICE1
IRRITABILITY1
INSOMNIA1
WITHDRAWAL SYNDROME1





Filtered ChEMBL targets:

Target UniProtKB ID Activity in nm Target Name Target gene
P51151 1258.9 Ras-related protein Rab-9A RAB9A_HUMAN



Toxicity information:

Toxicity class: 4
Toxicity type: hepatic
LD50: 485 mg/kg



External links:

ChEBML: CHEMBL1177
DrugBank: DB01230